BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
65.29
-0.32 (-0.49%)
At close: Aug 27, 2026, 4:00 PM EDT
64.00
-1.29 (-1.98%)
After-hours: Aug 27, 2026, 5:28 PM EDT
BioMarin Pharmaceutical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,407 | 3,221 | 2,854 | 2,419 | 2,096 | 1,846 |
Revenue Growth | 11.20% | 12.87% | 17.97% | 15.42% | 13.53% | -0.76% |
Gross Profit Gross Profit Growth | 1,736 | 1,701 | 1,526 | 1,140 | 943.41 | 746.97 |
Operating Income Operating Income Growth | 499.75 | 650.73 | 474.21 | 185.77 | 54.68 | -74.32 |
Net Income Net Income Growth | 72.97 | 348.9 | 426.86 | 167.65 | 141.56 | -64.08 |
Earnings Per Share EPS Growth | 0.38 | 1.80 | 2.21 | 0.87 | 0.75 | -0.35 |
EPS Growth | -88.85% | -18.24% | 153.71% | 16.00% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
VOXZOGO VOXZOGO Growth | 964.19 | 926.92 | 735.09 | 469.88 | 169.13 | 5.86 |
VIMIZIM VIMIZIM Growth | 792.86 | 792.05 | 739.78 | 701.05 | 663.74 | 623.15 |
NAGLAZYME NAGLAZYME Growth | 507.57 | 485.4 | 479.58 | 420.29 | 443.79 | 380.45 |
PALYNZIQ PALYNZIQ Growth | 458.83 | 433.31 | 355.05 | 303.92 | 255.03 | 237.47 |
BRINEURA BRINEURA Growth | 195.82 | 186.4 | 169.08 | 161.89 | 154.33 | 128.03 |
ALDURAZYME ALDURAZYME Growth | 183.38 | 208.51 | 183.89 | 131.25 | 128.42 | 122.77 |
KUVAN KUVAN Growth | 95.68 | 99.53 | 120.9 | 180.77 | 227.58 | 285.78 |
ROCTAVIAN ROCTAVIAN Growth | 30.28 | 35.64 | 26.07 | 3.49 | - | - |
Royalty and Other Royalty and Other Growth | 42.01 | 53.49 | 44.47 | 46.69 | 54.01 | 62.78 |
Revenue (Total) Revenue (Total) Growth | 3,407 | 3,221 | 2,854 | 2,419 | 2,096 | 1,846 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 874.01 | 1,561 | 1,138 | 1,074 | 1,292 | 1,014 |
Total Debt Total Debt Growth | 4,202 | 642.87 | 633.97 | 1,134 | 1,120 | 1,123 |
Net Cash (Debt) Net Cash Growth | -3,328 | 917.74 | 503.74 | -60.07 | 171.63 | -109.51 |
Net Cash Growth | - | 82.19% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -16.97 | 4.65 | 2.56 | -0.31 | 0.91 | -0.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 857.09 | 827.99 | 572.84 | 159.26 | 175.9 | 304.54 |
Capital Expenditures CapEx Growth | -118.91 | -103.04 | -85.42 | -96.69 | -120.96 | -95.58 |
Free Cash Flow Free Cash Flow Growth | 738.18 | 724.96 | 487.42 | 62.57 | 54.94 | 208.96 |
Free Cash Flow Growth | 6.23% | 48.73% | 679.02% | 13.88% | -73.71% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.97% | 52.81% | 53.49% | 47.14% | 45.01% | 40.46% |
Operating Margin | 14.67% | 20.20% | 16.62% | 7.68% | 2.61% | -4.03% |
Pretax Margin | 4.38% | 14.98% | 18.98% | 7.79% | 7.14% | -4.08% |
Profit Margin | 2.14% | 10.83% | 14.96% | 6.93% | 6.75% | -3.47% |
FCF Margin | 21.67% | 22.50% | 17.08% | 2.59% | 2.62% | 11.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 172.28 | 32.72 | 29.35 | 108.34 | 135.87 | - |
Forward PE | 10.73 | 12.37 | 17.86 | 38.98 | 39.00 | 85.79 |
P/FCF Ratio | 17.12 | 15.75 | 25.70 | 290.28 | 350.06 | 77.63 |
PS Ratio | 3.71 | 3.54 | 4.39 | 7.51 | 9.18 | 8.79 |